ArticleJournal of the American Heart Association2025
Influence of Multiple Risk Factor Management on the Onset and Progression of Chronic Kidney Disease in Patients With Hypertension.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with hypertension face a significantly elevated risk of renal dysfunction. However, whether this risk can be mitigated by joint risk factor control remains uncertain.
methodsUsing Cox proportional hazards models, this study investigated the association between the number of controlled baseline risk factors (systolic blood pressure, low-density lipoprotein cholesterol, fasting blood glucose, and body mass index) and the development and progression of chronic kidney disease.
resultsWe analyzed 77 356 participants with hypertension and 1:1 age- and sex-matched counterparts without hypertension for incident chronic kidney disease over a median follow-up of 13.40 years. Among participants with hypertension, each additional controlled risk factor was associated with an 18% lower risk of chronic kidney disease (hazard ratio [HR], 0.82 [95% CI, 0.81-0.84]), and controlling all 4 factors (versus ≤1) reduced the risk by 42% (HR, 0.58 [95% CI, 0.52-0.63]). Effective multifactorial management progressively narrowed the risk gap between hypertensive and normotensive individuals. Chronic kidney disease progression was assessed in 9543 participants with hypertension and 6799 participants without hypertension over 11.88 years. Each additional controlled risk factor was associated with an 18% lower progression risk (HR, 0.82 [95% CI, 0.78-0.86]). Controlling 3 factors was sufficient to eliminate the excess progression risk between groups with hypertension and groups without hypertension, while controlling all 4 factors lowered the risk by 31% (HR, 0.69 [95% CI, 0.53-0.89]).
conclusionsThis study demonstrates a clear dose-response relationship between the number of controlled risk factors and the magnitude of kidney risk reduction. A comprehensive, multifactorial control strategy can progressively reduce and potentially normalize the excess kidney risk in hypertensive individuals. These findings support a more quantitative and stage-specific approach to hypertension management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.